-
-
-
-
-
-
-
Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting
-
-
-
-
-
-
-
Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1
-
-
-
-
-
-
-
Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO
-
-
-
-
-
-
-
Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
-
-
-
-
-
-
-
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
-
-
-
-
-
-
-
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
-
-
-
-
-
-
-
Evofem Biosciences (EVFM) Reports FY23 Net Product Sales of Phexxi of $18.2M
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

